The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Mitchell Boshkos
No Relationships to Disclose
 
Maria Julia Moura Nascimento Santos
No Relationships to Disclose
 
Rebecca Tidwell
No Relationships to Disclose
 
Sagar Mukhida
No Relationships to Disclose
 
Patrick Pilié
Consulting or Advisory Role - Novartis; Pfizer
Patents, Royalties, Other Intellectual Property - Patent Pending- biomarker
 
Sumit Subudhi
Stock and Other Ownership Interests - Apricity Health
Honoraria - Arcus Biosciences; Bristol Myers Squibb; Dendreon; Hervolution; Johnson & Johnson; Merck; Novartis
Consulting or Advisory Role - Pfizer
Research Funding - Amgen (Inst); Arcus Biosciences (Inst); Bristol-Myers Squibb (Inst); Macrogenics (Inst); Regeneron (Inst); Tarus Therapeutics (Inst)
 
Ana Aparicio
Honoraria - Advanced Accelerator Applications/Novartis; Astellas Pharma; Bayer; Bristol-Myers Squibb Pharmaceuticals; Daiichi Sankyo; Genzyme; GlaxoSmithKline; Janssen; Pfizer
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; American Cancer Society; Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; Daiichi Sankyo Inc.; Genzyme; GlaxoSmithKline; Janssen Research & Development; Pfizer
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Janssen (Inst); Polaris (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; GlaxoSmithKline
 
Bilal Siddiqui
Honoraria - Cancer Expert Now; Cardinal Health; Curio Science; DAVA Pharmaceuticals
Consulting or Advisory Role - Amgen; Bayer; Johnson and Johnson; Merck; Pfizer; Survivornet
Research Funding - Amgen (Inst); Cancer Research Institute; Conquer Cancer, the ASCO Foundation; Johnson & Johnson/Janssen (Inst); Prostate Cancer Foundation; Regeneron (Inst)
Travel, Accommodations, Expenses - Cardinal Health; Curio Science; Merck
 
Justin Gregg
Consulting or Advisory Role - Bayer; J&J; Pfizer
 
Amado Zurita
No Relationships to Disclose
 
Daniel Frigo
Employment - Biocity Biopharmaceuticals (I); March Biosciences (I)
Leadership - March Biosciences (I)
Stock and Other Ownership Interests - Barricade Therapeutics (I); Biocity Biopharmaceuticals (I); March Biosciences (I)
Patents, Royalties, Other Intellectual Property - Frigo, D.E., A.R. Means and D.P. McDonnell. “CaMKK-? as a Target for Treating Cancer”. United States Patent 9999620. Issued 6/17/2018. “Novel Therapeutic Targets in the Androgen Receptor Signaling Pathway”. European Patent 2606130. Issued 3/13/2019.
 
Paul Corn
Research Funding - Janssen Oncology (Inst)
 
Chad Tang
Employment - MD Anderson Cancer Center
Consulting or Advisory Role - Boston Scientific; Elekta; MOLLI Surgical; Telix Pharmaceuticals
Research Funding - Myriad Genetics (Inst); Noxopharm (Inst)
Patents, Royalties, Other Intellectual Property - I have a patent on the utilization of a monoclonal antibody and we license this for use. We receive royalties <$1000 per year on this license.
Travel, Accommodations, Expenses - Vision RT
Other Relationship - Osler Institute; Wolters Kluwer
 
Christopher Logothetis
No Relationships to Disclose
 
Andrew Hahn
Honoraria - Binacea; Curio Science; Dava Oncology; IDEOlogy Health; Kaplan Partners in Knowledge; Mashup Media; Medscape; MJH Life Sciences
Consulting or Advisory Role - AVEO; Eisai; Exelixis; Intellisphere; Janssen Scientific Affairs; Pfizer; Tolmar
Research Funding - Bayer; Bristol Myers Squibb; Eisai (Inst); Halda Therapeutics
Travel, Accommodations, Expenses - Dava Oncology